Close Menu
    • Home
    • Contact Us
    Front Page Arabia: Arabia’s biggest stories, up front.Front Page Arabia: Arabia’s biggest stories, up front.
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Front Page Arabia: Arabia’s biggest stories, up front.Front Page Arabia: Arabia’s biggest stories, up front.
    Home » Russia develops dual-action cancer drug, a game-changer in oncology
    Featured News

    Russia develops dual-action cancer drug, a game-changer in oncology

    March 13, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Scientists at Tomsk Polytechnic University (TPU) have developed and patented Russia’s first theranostic pair original radiopharmaceuticals designed for both the diagnosis and treatment of prostate cancer. According to the TPU press service, the initial phase of pilot clinical trials has been successfully completed, marking a significant advancement in Russian oncology research.

    Russia develops dual-action cancer drug, a game-changer in oncology

    The development is part of a growing field known as theranostics, which combines diagnostic and therapeutic applications into a single approach to cancer treatment. Until now, only two theranostic molecules have been available globally, both developed by foreign companies, targeting neuroendocrine tumors and prostate cancer.

    The Tomsk scientists‘ achievement establishes Russia’s first domestically developed alternative in this field. Roman Zelchan, senior researcher at the Oncoteranostics Research Centre at TPU’s Research School of Chemical and Biomedical Technologies, emphasized the significance of this breakthrough. “We can safely say that Tomsk Polytechnic University has developed the first domestic theranostic pair,” he stated.

    Understanding theranostics: The future of cancer treatment

    Zelchan is also a leading research associate at the Department of Radionuclide Therapy and Diagnostics at the Tomsk Research Institute of Oncology, part of the Tomsk Medical Research Centre. The newly developed radiopharmaceuticals are based on the BQ-PSMA compound, enabling both diagnostic and therapeutic applications. When combined with the diagnostic radioactive isotope technetium-99m, the compound functions as a “signal beacon” that identifies tumor cells.

    The therapeutic version, incorporating lutetium-177, enhances the compound’s ability to target and destroy cancer cells effectively. Prostate cancer remains one of the most commonly diagnosed cancers worldwide, affecting approximately one in eight men during their lifetime. The introduction of this Russian theranostic technology could expand treatment options and improve outcomes for patients.

    The researchers at TPU believe their development represents a major step in advancing personalized cancer treatment within Russia and beyond. With further clinical trials and regulatory approvals, the theranostic pair could potentially become an integral part of modern oncology protocols. This breakthrough aligns with a broader push in Russia to advance domestic pharmaceutical and medical technology sectors, reducing reliance on foreign innovations. – By Eurasian Newswire News Desk.

    Related Posts

    Network International and AdalFi Partner to Unlock Data-Driven Lending Across the Middle East and Africa

    November 16, 2026

    Narwal Unveils Flow 2: Revolutionary FlowWash Mopping System with VLM OmniVision Intelligence

    November 14, 2026

    Integrated Identity Unveils Proprietary Global Media Infrastructure

    October 22, 2026

    ConSynSer Sets a New Standard for Guaranteed Content Syndication

    October 14, 2026

    ePlanet Brokers Review 2026: Forex Expo Dubai, Best Broker Award and a Growing Focus on Transparency

    October 13, 2026

    IGNITE Launches MENA Platform in Dubai, Bringing Together Entrepreneurship, AI-Powered Learning and Global Consumer Brands

    October 12, 2026
    Latest News

    Petrol price jump lifts South Africa inflation as SARB weighs rates

    November 18, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    ASEAN signs digital economy pact eyeing $2 trillion by 2030

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026

    Damascus becomes Air Arabia Dammam’s second foreign route

    November 17, 2026

    Etihad plans seven weekly Calgary flights as demand grows

    November 17, 2026

    Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

    November 17, 2026
    © 2026 Front Page Arabia | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.